Association of MC1R variants and risk of melanoma in melanoma-prone families with CDKN2A mutations

被引:0
作者
Goldstein, AM
Landi, MT
Tsang, S
Fraser, MC
Munroe, DJ
Tucker, MA
机构
[1] NCI, Genet Epidemiol Branch, Div Canc Epidemiol & Genet, NIH,Dept Hlth & Human Serv, Bethesda, MD 20892 USA
[2] NCI, Lab Mol Technol, Frederick, MD 21701 USA
[3] Sci Applicat Int Corp, Frederick, MD USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Major risk factors for melanoma include many nevi, especially dysplastic nevi, fair pigmentation, freckling, poor tanning ability, and germ line mutations in the CDKN2A, CDK4, or MC1R genes. We evaluated the relationship between MC1R and melanoma risk in CDKN2A melanoma-prone families with extensive clinical and epidemiologic data. We studied 395 subjects from 16 American CDKN2A families. Major melanoma risk factors were assessed by clinical examination or questionnaire; MC1R was sequenced. Odds ratios were estimated by unconditional and conditional logistic regression models. We examined the distribution of MC1R variants and median ages at melanoma diagnosis in multiple primary melanoma (MPM) and single primary melanoma (SPM) patients. Presence of multiple MC1R variants was significantly associated with melanoma, even after adjustment for major melanoma risk factors. All 40 MPM patients had at least one MC1R variant; 65% of MPM patients versus only 17% of SPM patients had at least two MC1R variants (P < 0.0001). For all 69 melanoma patients combined, as well as the 40 MPM patients, there was a statistically significant decrease in median age at diagnosis as numbers of MCIR variants increased (P = 0.010 and P = 0.008, respectively). In contrast, no significant reduction in age at melanoma diagnosis was observed for SPM patients (P = 0.91). The current study suggests that the presence of multiple MCIR variants is associated with the development of multiple melanoma tumors in patients with CDKN2A mutations. Additional studies are needed to confirm these findings and to explore the mechanisms that may contribute to this relationship.
引用
收藏
页码:2208 / 2212
页数:5
相关论文
共 20 条
[1]  
Armstrong B. K., 1996, CANC EPIDEMIOLOGY PR, V2nd, P1282
[2]   MC1R genotype modifies risk of melanoma in families segregating CDKN2A mutations [J].
Box, NF ;
Duffy, DL ;
Chen, W ;
Stark, M ;
Martin, NG ;
Sturm, RA ;
Hayward, NK .
AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 69 (04) :765-773
[3]   Cyclic AMP a key messenger in the regulation of skin pigmentation [J].
Buscà, R ;
Ballotti, R .
PIGMENT CELL RESEARCH, 2000, 13 (02) :60-69
[4]  
CHAUDRU V, 2003, P 1 INT MEL RES C
[5]   Interactive effects of MC1R and OCA2 on melanoma risk phenotypes [J].
Duffy, DL ;
Box, NF ;
Chen, W ;
Palmer, JS ;
Montgomery, GW ;
James, MR ;
Hayward, NK ;
Martin, NG ;
Sturm, RA .
HUMAN MOLECULAR GENETICS, 2004, 13 (04) :447-461
[6]   Pleiotropic effects of the melanocortin 1 receptor (MC1R) gene on human pigmentation [J].
Flanagan, N ;
Healy, E ;
Ray, A ;
Philips, S ;
Todd, C ;
Jackson, IJ ;
Birch-Machin, MA ;
Rees, JL .
HUMAN MOLECULAR GENETICS, 2000, 9 (17) :2531-2537
[7]   Genotype-phenotype relationships in US melanoma-prone families with CDKN2A and CDK4 mutations [J].
Goldstein, AM ;
Struewing, JP ;
Chidambaram, A ;
Fraser, MC ;
Tucker, MA .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (12) :1006-1010
[8]  
GOLDSTEIN AM, 2004, GENETIC PREDISPOSITI, P352
[9]   Genetic testing for melanoma [J].
Kefford, R ;
Bishop, JN ;
Tucker, M ;
Bressac-de-Paillerets, B ;
Bianchi-Scarrá, G ;
Bergman, W ;
Goldstein, A ;
Puig, S ;
Mackie, R ;
Elder, D ;
Hansson, J ;
Hayward, N ;
Hogg, D ;
Olsson, H .
LANCET ONCOLOGY, 2002, 3 (11) :653-654
[10]   Melanocortin 1 receptor (MC1R) gene variants are associated with an increased risk for cutaneous melanoma which is largely independent of skin type and hair color [J].
Kennedy, C ;
ter Huurne, J ;
Berkhout, M ;
Gruis, N ;
Bastiaens, M ;
Bergman, W ;
Willemze, R ;
Bavinck, JNB .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2001, 117 (02) :294-300